FDA recalls thyroid medication sold nationwide over potency concern

The U.S. Food and Drug Administration has issued a nationwide recall for specific lots of levothyroxine sodium tablets. Major Pharmaceuticals distributed these tablets, which are standard treatments for hypothyroidism and other thyroid conditions.

The recall stems from a potency issue. Testing indicates these specific tablets may contain a lower amount of the active ingredient than what is stated on the bottle. Consequently, patients might not receive the full dosage required for effective hormone regulation.

Health authorities have classified this as a Class II recall. This category means that while the risk of serious health problems remains remote, the product could still result in temporary or reversible medical consequences for users. The medication is essential for hormone balance, so patients should not discontinue use without consulting a medical professional.

To determine if your medication is affected, you must check the manufacturer, lot number, and expiration date on your prescription packaging against the official FDA recall database. If your specific lot is part of the recall, contact your pharmacist or healthcare provider immediately to arrange for a replacement. Do not stop taking your medication until you speak with your doctor, as an abrupt interruption can worsen thyroid-related symptoms.

Always verify your prescription details directly through the manufacturer or official government health portals to ensure you have the correct information regarding your specific bottle.